Jacobs Levy Equity Management »

Upstream Bio shares owned by Jacobs Levy Equity Management

Quarter-by-quarter ownership of Upstream Bio (UPB) shares owned by Jacobs Levy Equity Management from 13F filings

Historical chart of Jacobs Levy Equity Management investment in Upstream Bio

Tip: Access up to 7 years of quarterly data

All positions including Upstream Bio held by Jacobs Levy Equity Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Upstream Bio by Jacobs Levy Equity Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.8M 253k 6.92

More positions owned by Jacobs Levy Equity Management

NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl C (GOOG)
Apple (AAPL)
Micron Technology (MU)
Microsoft Corporation (MSFT)
Kla Corp Com New (KLAC)
Booking Holdings (BKNG)
Fortinet (FTNT)
Amazon (AMZN)
Crowdstrike Hldgs Cl A (CRWD)
Bank of New York Mellon Corporation (BNY)
Target Corporation (TGT)
Interactive Brokers Group In Com Cl A (IBKR)
Comfort Systems USA (FIX)
General Motors Company (GM)

View all positions for Jacobs Levy Equity Management

Top funds holding Upstream Bio

FMR
OrbiMed Advisors
Norges Bank Investment Management
BlackRock
Decheng Capital
Enavate Sciences GP
Vanguard Capital Management
Millennium Management
D. E. Shaw & Co
Jpmorgan Chase & Co
Qube Research & Technologies
Parkman Healthcare Partners
Geode Capital Management
SEB Asset Management AB
Woodline Partners

View all funds holding Upstream Bio